Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ishaque Pulikkal Kadamberi
Observed names:
I. Pulikkal Kadamberi,
Ishaque Kadamberi,
Ishaque P. Kadamberi,
Ishaque Pulikkal,
Kadamberi, Ishaque Pulikkal
Institutions:
Medical College of Wisconsin,
Medical College of Wisconsin Cancer Center
Observed institutions:
University of Pittsburgh,
Medical College of Wisconsin,
VA Pittsburgh Healthcare System,
Medical College of Wisconsin Cancer Center,
Rajiv Gandhi Centre for Biotechnology
OpenAlex ID:
A5044506702
Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer
2022
·
Prachi Gupta
, Ishaque Pulikkal Kadamberi
, et al.
·
Advanced Science
·
73
PDF
Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
2021
·
Anjali Geethadevi
, Ajay Nair
, et al.
·
Cancer Research
·
70
PDF
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
2021
·
Jasmine George
, Yongsheng Li
, et al.
·
Cell Reports
·
67
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling
2020
·
Deepak Parashar
, Bindu Nair
, et al.
·
Cancer Research
·
51
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance
2022
·
Deepak Parashar
, Anjali Geethadevi
, et al.
·
Cancers
·
25
PDF
Optimized proximity ligation assay (PLA) for detection of RNA-protein complex interactions in cell lines
2022
·
Jasmine George
, Sonam Mittal
, et al.
·
STAR Protocols
·
23
PDF
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer
2024
·
Anjali Geethadevi
, Zhiqiang Ku
, et al.
·
npj Precision Oncology
·
19
Cigarette smoke downregulates Nur77 to exacerbate inflammation in chronic obstructive pulmonary disease (COPD)
2020
·
Aravind T. Reddy
, Sowmya P. Lakshmi
, et al.
·
PLoS ONE
·
14
PDF
Strategies for imaging mitophagy in high-resolution and high-throughput
2017
·
Deepa Indira
, Shankara Narayanan Varadarajan
, et al.
·
European Journal of Cell Biology
·
14
Fluorinated triphenylphosphonium analogs improve cell selectivity and in vivo detection of mito-metformin
2022
·
Mahmoud AbuEid
, Robert F. Keyes
, et al.
·
iScience
·
11
PDF
eIF4E Enriched Extracellular Vesicles Induce Immunosuppressive Macrophages through HMGCR‐Mediated Metabolic Rewiring
2025
·
Sonam Mittal
, Minal Nenwani
, et al.
·
Advanced Science
·
7
PDF
Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
2023
·
Sonam Mittal
, Ishaque Pulikkal Kadamberi
, et al.
·
Experimental Hematology and Oncology
·
6
PDF
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
2023
·
Jasmine George
, Yongsheng Li
, et al.
·
Cell Reports
·
6
Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958
2022
·
Deepak Parashar
, Anjali Geethadevi
, et al.
·
Cancers
·
4
PDF
Abstract 2321: Tumor-derived extracellular vesicles induce macrophages immunosuppressive polarization to promote ovarian cancer progression
2023
·
Sonam Mittal
, Ishaque Pulikkal Kadamberi
, et al.
·
Cancer Research
·
3
Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer
2026
·
Jasmine George
, Xiaolong Ma
, et al.
·
Nature Communications
·
1
Abstract 4284: Macrophage reprogramming and immune suppression through extracellular vesicles loaded eIF4A1in ovarian cancer
2024
·
Sonam Mittal
, Ishaque Pulikkal Kadamberi
, et al.
·
Cancer Research
·
1
Abstract 5314: Selinexor, a selective inhibitor of nuclear export (SINE) compound, enhances the anti-tumor activity of Eribulin in leiomyosarcoma
2022
·
Sonam Mittal
, Ishaque Pulikkal
, et al.
·
Cancer Research
·
1
MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer
2026
·
Meenakshi Pradeep
, Ishaque Pulikkal Kadamberi
, et al.
·
Molecular Therapy Oncology
Abstract B123: Oncostatin M receptor (OSMR) is a tumor-selective target in pancreatic ductal adenocarcinoma: Quantitative expression in primary and metastatic patient tumors
2026
·
Naveenkumar Chandrashekhar
, Edward Opichka
, et al.
·
Cancer Research
TAOK3 marks an invasion‑competent epithelial subset in cervical cancer, and its inhibition restrains tumor growth, sensitizes to paclitaxel, and remodels the immune microenvironment
2026
·
Marissa Iden
, Rachel Schmidt
, et al.
·
Research Square
TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer
2026
·
Marissa Iden
, Rachel Schmidt
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Spatial transcriptomic profiling of adult-type granulosa cell tumors of the ovary
2026
·
Sarah McDonald
, Anjishnu Banerjee
, et al.
·
Gynecologic Oncology
Preclinical assessment of combined PD-1 and CTLA-4 inhibition for adult type granulosa cell tumors of the ovary
2026
·
Sarah McDonald
, Theresa Dlugi
, et al.
·
Gynecologic Oncology
Abstract A068: Post-transcriptional regulation driven by NAT10 in ovarian cancer
2025
·
Sonam Mittal
, Shirng-Wern Tsaih
, et al.
·
Cancer Research
Show more works
View as search
Works count:
43
Citation count:
396
H-index:
10
I10-index:
10
Year
Topic
Type
